Shanshan Lin

Researcher @Hopkins_GIM ScM @JohnsHopkinsEPI

[Arjun (Raj) Manrai @arjunmanrai]

How should we evaluate LLMs in medicine given increasing benchmark saturation? Is simulation meaningful? Does LLM performance on standardized exams still contain signal?

We explore in the new @NEJM_AI and argue that when it comes to benchmarks, humans are (still) the only way

[NEJM @NEJM]

Special Article: Implications of Race Adjustment in Lung-Function Equations https://t.co/uQ83ohdbbd

Editorial: Beyond Diagnostics — Removing Race from Lung-Function Test Interpretation https://t.co/DTrbUi2OeR

#ATS2024 @atscommunity

[Matthias Egger @eggersnsf]

Question:
How are observational studies that explicitly aim to emulate a target trial reported?
Answer:
Not well - reporting could have been more consistent and complete for many studies.
https://t.co/6UWRkjkKp4
@_MiguelHernan

[Shanshan Lin @ShanshanLin03]

@jm_alexia Agreed.

[Shanshan Lin @ShanshanLin03]

@fotikat Haha thanks😊and I think so too!!

[Shanshan Lin @ShanshanLin03]

#JHPrecisionMed23

[Shanshan Lin @ShanshanLin03]

Yesss and i am grateful for that. 🙏

[Julie Bastarache @JulesBass6]

If I could give aspiring scientists and trainees one piece of advice it would be this: Find a mentor who cares enough about you to do this 👇

#Mentorship #AcademicChatter #PhysicianScientist #CareerAdvice

[Eric Topol @EricTopol]

The @NEJM is getting serious about covering #AI in medicine with a new series and journal. A #GPT4 preview, review and editorial today
This important advance is covered in-depth in a new book
https://t.co/hGyrJt4yt7

[やまこじ @higashiyama5555]

うらら「はとさん待て待て〜」

#東山動植物園　#アジアゾウ

[Shanshan Lin @ShanshanLin03]

Introducing the Library of Guidance for Health Scientists (LIGHTS)
A Living Database for Methods Guidance:https://t.co/6NOYQTXsAg

https://t.co/hmOrBVNCPM

[Mina T. @Mina__T]

Taking over for @Pottegard

Paper #18: We talk about target trials often, but many of these principles have a long-standing history. @LundJenny walks through the bases for active-comparator/new-user design and how to implement a study #pharmepi

https://t.co/HyDwfU6Hdb

[Keri N Althoff @kerinalthoff]

Today's #GEMRIP features scientifically fearless trainees and their investigations of:

1) guaranteed income on health outcomes (@EpiHoodScholar)

2) #COVID booster uptake (Victoria Scott)

3) the impact of under-ascertained #mortality on inference (Sita Lujintanon)

🤩🤩🤩

[Shanshan Lin @ShanshanLin03]

Literally me during weekend

[Shanshan Lin @ShanshanLin03]

@pohungVChen @JohnsHopkinsEPI @kerinalthoff Yes! And multilevel statistical analysis was moved to the second term

[Shanshan Lin @ShanshanLin03]

My first day being a second-year epidemiology master student at @JohnsHopkinsEPI: taking classes, meeting with friends, working on a manuscript… Love everything here!
@kerinalthoff #FirstDayofSchool #GenEpiMethods

[Shanshan Lin @ShanshanLin03]

@EpiHoodScholar @RWJF @HPRScholars Congratulations!🎊🎉 Well-deserved!

[Shanshan Lin @ShanshanLin03]

@Menon_Ga @JohnsHopkinsEPI @kerinalthoff Thank you Gayathri😊 Best wishes for your next adventure!!

[Shanshan Lin @ShanshanLin03]

@kerinalthoff @JohnsHopkinsEPI @ngderekk Thanks Dr. Althoff! Looking forward to seeing you on campus!

[Journal of Hepatology @JHepatology]

Our February issue is out‼️

Read the selection of the month:

➡️AI model to predict #HCC risk in patients with chronic #HBV

And much more at👉https://t.co/xf1McKErDX

#LiverTwitter

[The Lancet @TheLancet]

@tomhemmingk Protecting the next generation of Europeans against liver disease: findings & recommendations from the @EASLNews-Lancet Commission 👇 https://t.co/lJ3iwBgqSw